Glial fibrillary acidic protein (GFAP) expression can be used to infer astrocyte activation levels, and as a result, may support the early detection of Alzheimer's disease (AD). To date ...

Longitudinal increases in NfL and GFAP levels were associated with cognitive decline among patients with type 2 diabetes and obesity. Longitudinal increases in neurofilament light chain (NfL ...

Glial fibrillary acidic protein (GFAP) is a marker of astrocytic differentiation and is expressed in astroglial tumors. On the basis of the hypothesis that GFAP might be released from these tumors ...